Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The purpose of this study is to identify blood markers that have the ability to diagnose liver cancer with improved accuracy, so that it can be used alone or in conjunction with alpha-feto protein (AFP)
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patients diagnosed with liver cancer based on biopsy or serum AFP level, associated with characteristic hypervascular liver tumors on triphasic spiral CT scan or MRI.
• Patients with non-cancer liver conditions such as cirrhosis, adenoma, cholangioma, or nodular hyperplasia.
• Patients with hepatitis B or hepatitis C viral infections not associated with liver cancer.
Locations
United States
California
Stanford University School of Medicine
RECRUITING
Stanford
Contact Information
Primary
Mei-Sze Chua
mchua@stanford.edu
650-724-3525
Time Frame
Start Date: 2004-11
Estimated Completion Date: 2025-12
Participants
Target number of participants: 600
Related Therapeutic Areas
Sponsors
Leads: Stanford University